Changes of blood count, lymphocyte subpopulations and immunoglobulin levels in nephroblastoma long term survivors

Neoplasma

Volumn 56, Issue 1, 2009, Pages 9-12

  Eckschlager, T ^a   Radvanska, J ^a   Slaby, K ^a   Prusa, R ^a   Hochova, I ^a   Radvansky, J ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Blood count; Immunoglobulin G, A, M serum levels; Lymphocyte subpopulations; Nephroblastoma long term survivors

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD CELL COUNT; CANCER IMMUNOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; DISEASE COURSE; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NEPHROBLASTOMA; QUALITY OF LIFE; RECURRENT CANCER; SCHOOL CHILD; SURVIVAL TIME; TURBIDIMETRY; BLOOD; IMMUNOLOGY; KIDNEY TUMOR; SURVIVOR;

ADOLESCENT; ADULT; BLOOD CELL COUNT; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS; KIDNEY NEOPLASMS; LYMPHOCYTE SUBSETS; MALE; SURVIVORS; WILMS TUMOR;

EID: 66549106265     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_01_9     Document Type: Article

References (13)

1. Schwartz CL. Long-term survivors of childhood cancer: The late effects of therapy. Oncologist 1999; 4: 45-54. (Pubitemid 29102454)
2. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004; 54: 208-236. doi:10.3322/canjclin.54.4.208 PMid:15253918
3. Green DM, D'Angio GJ, Beckwith JB et al. Wilms tumor. CA Cancer J Clin 1996; 46: 46-63. doi:10.3322/canjclin.46.1.46 PMid:8548525
4. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist 2005; 10: 815-826. doi:10.1634/theoncologist. 10-10-815 PMid:16314292
5. Smelhaus V, Koutecky J. Patient summary of the paediatric oncology in teaching hospital in Motol and the development of the results of their therapy in the years 1976-2000. /in czech/ Klinicka onkologie 2003, Suppl: 85-92
6. Eckschlager T, Prusa R, Hladikova M et al. Lymphocyte sub-populations and immunoglobulin levels in Hodgkin's disease survivors. Neoplasma 2004; 51: 261-264. (Pubitemid 38915542)
7. Weinshel EL, Peterson BA. Hodgkin's disease. CA Cancer J Clin 1993; 43: 327-346. doi:10.3322/canjclin.43.6.327 PMid:8242436
8. Kowalczyk D, Szymik S, Grochowski J et al. Immunological reactivity in children with Wilms' tumor. Neoplasma 1986; 33: 509-518.
9. Romero RR, Alberu J, Correa-Rotter R et al. Serum erythropoietin levels in kidney donors after renal transplantation. Transplantation 2000; 70: 386-387. doi:10.1097/00007890- 200007270-200100027 PMid:10933169 (Pubitemid 30602763)
10. Michon J. Incidence of anemia in pediatric cancer patients in Europe: Results of a large, international survey. Med Pediatr Oncol 2002; 39: 448-450. doi:10.1002/mpo.10183 PMid:12203661 (Pubitemid 34976946)
11. Pawlicki M, Zuchowska-Vogelgesang B, Ziobro M et al. Late hematologic status after chemotherapy observed in patients 3 to 10 years after treatment. Przegl Lek 1995; 52: 344-346. (in Polish)
12. Carli M, Frascella E, Tournade MF et al. Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Med Pediatr Oncol 1997; 29: 239-244. doi:10.1002/(SICI)1096-911X(199710)29:4<239: :AID-MPO1> 3.0.CO;2-N PMid:9251727
13. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56: 339-347. (Pubitemid 17158825)